These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

108 related items for PubMed ID: 8094675

  • 1. Long-term treatment with zidovudine in patients with human immunodeficiency virus (HIV)-associated thrombocytopenia: modes of response and correlation with markers of HIV replication.
    Cinque P, Landonio G, Lazzarin A, Nosari AM, Ruggieri A, Coen M, Meraviglia P, Gringeri A, Gallo L, Quirino T.
    Eur J Haematol; 1993 Jan; 50(1):17-21. PubMed ID: 8094675
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Long-term zidovudine treatment of asymptomatic HIV-1-infected subjects.
    Mulder JW, de Wolf F, Goudsmit J, Cload PA, Coutinho RA, Fiddian AP, Schellekens PT, van der Noordaa J, Lange JM.
    Antiviral Res; 1990 Mar; 13(3):127-38. PubMed ID: 1972321
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. HIV-seropositive thrombocytopenia: the action of zidovudine.
    Boyar A, Beall G.
    AIDS; 1991 Nov; 5(11):1351-6. PubMed ID: 1768384
    [Abstract] [Full Text] [Related]

  • 6. Response of AIDS-related thrombocytopenia to intravenous and oral azidothymidine (3'-azido-3'-deoxythymidine).
    Gottlieb MS, Wolfe PR, Chafey S.
    AIDS Res Hum Retroviruses; 1987 Nov; 3(2):109-14. PubMed ID: 3113461
    [Abstract] [Full Text] [Related]

  • 7. Quantification of HIV-1 virus load under zidovudine therapy in patients with symptomatic HIV infection: relation to disease progression.
    Molina JM, Ferchal F, Chevret S, Barateau V, Poirot C, Morinet F, Modai J.
    AIDS; 1994 Jan; 8(1):27-33. PubMed ID: 7912084
    [Abstract] [Full Text] [Related]

  • 8. HIV-related thrombocytopenia: is zidovudine a therapeutic option?
    Nathwani D, Green ST, Kennedy DH, Love WC, Goldberg D, Fallon RJ.
    J Infect; 1989 Nov; 19(3):288-90. PubMed ID: 2600447
    [No Abstract] [Full Text] [Related]

  • 9. Thrombocytopenia in children infected with human immunodeficiency virus: long-term follow-up and therapeutic considerations.
    Rigaud M, Leibovitz E, Quee CS, Kaul A, Nardi M, Pollack H, Lawrence R, DiJohn D, Krasinski K, Karpatkin M.
    J Acquir Immune Defic Syndr (1988); 1992 Nov; 5(5):450-5. PubMed ID: 1560341
    [Abstract] [Full Text] [Related]

  • 10. Comparison of two dose regimens of zidovudine in an open, randomized, multicentre study for severe HIV-related thrombocytopenia.
    Landonio G, Cinque P, Nosari A, Gafa S, Rizzo F, Coen M, Tirelli U, Caggese L, di Luzio Paparatti U, Lazzarin A.
    AIDS; 1993 Feb; 7(2):209-12. PubMed ID: 8466682
    [Abstract] [Full Text] [Related]

  • 11. Zidovudine for the treatment of thrombocytopenia associated with human immunodeficiency virus (HIV). A prospective study. The Swiss Group for Clinical Studies on the Acquired Immunodeficiency Syndrome (AIDS).
    Ann Intern Med; 1988 Nov 01; 109(9):718-21. PubMed ID: 3190058
    [Abstract] [Full Text] [Related]

  • 12. Interferon-alpha with zidovudine: safety, tolerance, and clinical and virologic effects in patients with Kaposi sarcoma associated with the acquired immunodeficiency syndrome (AIDS).
    Krown SE, Gold JW, Niedzwiecki D, Bundow D, Flomenberg N, Gansbacher B, Brew BJ.
    Ann Intern Med; 1990 Jun 01; 112(11):812-21. PubMed ID: 1971504
    [Abstract] [Full Text] [Related]

  • 13. Successful zidovudine therapy for HIV-related severe thrombocytopenia. Report of a sustained remission.
    Peña JM, Arnalich F, Barbado FJ, Dominguez A, Mostaza J, Valencia ME, Vazquez JJ.
    Acta Haematol; 1990 Jun 01; 83(2):86-8. PubMed ID: 2106201
    [Abstract] [Full Text] [Related]

  • 14. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE, Moore RD, Richman DD, Keruly J, Creagh T.
    Am Rev Respir Dis; 1992 Aug 01; 146(2):285-9. PubMed ID: 1362634
    [Abstract] [Full Text] [Related]

  • 15. Factors predictive of maternal-fetal transmission of HIV-1. Preliminary analysis of zidovudine given during pregnancy and/or delivery.
    Boyer PJ, Dillon M, Navaie M, Deveikis A, Keller M, O'Rourke S, Bryson YJ.
    JAMA; 1992 Aug 01; 271(24):1925-30. PubMed ID: 7911164
    [Abstract] [Full Text] [Related]

  • 16. Zidovudine-interferon-alpha combination therapy in patients with advanced human immunodeficiency virus type 1 infection: biphasic response of p24 antigen and quantitative polymerase chain reaction.
    Edlin BR, Weinstein RA, Whaling SM, Ou CY, Connolly PJ, Moore JL, Bitran JD.
    J Infect Dis; 1992 May 01; 165(5):793-8. PubMed ID: 1349031
    [Abstract] [Full Text] [Related]

  • 17. Toxic effects of zidovudine in asymptomatic human immunodeficiency virus-infected individuals with CD4+ cell counts of 0.50 x 10(9)/L or less. Detailed and updated results from protocol 019 of the AIDS Clinical Trials Group.
    Koch MA, Volberding PA, Lagakos SW, Booth DK, Pettinelli C, Myers MW.
    Arch Intern Med; 1992 Nov 01; 152(11):2286-92. PubMed ID: 1359846
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The effect of zidovudine on platelet count in HIV-infected individuals.
    Montaner JS, Le T, Fanning M, Gelmon K, Tsoukas C, Falutz J, O'Shaughnessy M, Wainberg MA, Ruedy J.
    J Acquir Immune Defic Syndr (1988); 1990 Nov 01; 3(6):565-70. PubMed ID: 2187071
    [Abstract] [Full Text] [Related]

  • 20. Response of severe HIV-associated thrombocytopenia to highly active antiretroviral therapy including protease inhibitors.
    Carbonara S, Fiorentino G, Serio G, Maggi P, Ingravallo G, Monno L, Bruno F, Coppola S, Pastore G, Angarano G.
    J Infect; 2001 May 01; 42(4):251-6. PubMed ID: 11545567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.